Kalkine has a fully transformed New Avatar.

Chemed Corp

Healthcare US CHE

400.76USD
-2.71(0.67%)

Last update at 2026-03-10T20:27:00Z

Day Range

397.77406.15
LowHigh

52 Week Range

480.58595.18
LowHigh

Fundamentals

  • Previous Close 403.47
  • Market Cap8899.45M
  • Volume198840
  • P/E Ratio36.76
  • Dividend Yield0.27%
  • EBITDA368.63M
  • Revenue TTM2225.16M
  • Revenue Per Share TTM148.31
  • Gross Profit TTM 765.09M
  • Diluted EPS TTM16.13

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 329.68M 350.31M 395.99M 261.61M 239.60M
Minority interest - - - - -
Net income 249.62M 268.55M 319.47M 219.92M 205.54M
Selling general administrative 358.73M 366.73M 330.22M 305.71M 270.21M
Selling and marketing expenses - - - - -
Gross profit 765.09M 769.80M 701.39M 617.43M 554.00M
Reconciled depreciation 59.17M 59.05M 56.58M 45.20M 38.86M
Ebit 343.50M 343.04M 389.68M 257.38M 244.59M
Ebitda 393.44M 411.23M 454.93M 311.35M 283.45M
Depreciation and amortization 49.94M 68.19M 65.25M 53.97M 38.86M
Non operating income net other - 9.14M 8.66M 8.76M 0.96M
Operating income 343.50M 343.04M 389.68M 257.38M 243.63M
Other operating expenses 1791.47M 1796.22M 1689.90M 1681.17M 1539.02M
Interest expense 4.58M 1.87M 2.35M 4.54M 4.99M
Tax provision 80.06M 81.76M 76.52M 41.69M 34.06M
Interest income 14.20M 6.82M 0.76M 0.51M 0.67M
Net interest income -4.22900M -1.49100M -1.59800M -4.02200M -4.31900M
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 80.06M 81.76M 76.52M 41.69M 34.06M
Total revenue 2134.96M 2139.26M 2079.58M 1938.56M 1782.65M
Total operating expenses 421.59M 426.76M 311.71M 360.05M 310.37M
Cost of revenue 1369.88M 1369.46M 1378.20M 1321.13M 1228.64M
Total other income expense net -13.81700M 7.28M 6.31M 4.23M 0.29M
Discontinued operations - - - - -
Net income from continuing ops 249.62M 268.55M 319.47M 219.92M 205.54M
Net income applicable to common shares 249.62M 268.55M 319.47M 219.92M 205.54M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1442.01M 1342.72M 1434.91M 1268.32M 975.53M
Intangible assets 99.73M 108.10M 118.08M 126.37M 68.25M
Earning assets - - - - -
Other current assets 48.81M 50.06M 32.78M 33.22M 29.80M
Total liab 643.30M 719.45M 533.71M 541.71M 384.19M
Total stockholder equity 798.72M 623.27M 901.20M 726.61M 591.33M
Deferred long term liab 1.70M 121.78M 109.12M 94.95M 86.21M
Other current liab 172.71M 39.03M 42.59M 43.76M 141.52M
Common stock 36.80M 36.51M 36.26M 35.81M 35.31M
Capital stock 36.80M 36.51M 36.26M 35.81M 35.31M
Retained earnings 2197.92M 1970.31M 1723.78M 1425.75M 1225.62M
Other liab 143.08M 131.42M 135.39M 102.83M 103.33M
Good will 581.29M 578.59M 578.59M 577.37M 510.57M
Other assets 57.98M 107.02M 408.84M 86.49M 74.83M
Cash 74.13M 32.90M 162.68M 6.16M 4.83M
Cash and equivalents 74.13M 32.90M 162.68M 6.16M 4.83M
Total current liabilities 297.20M 302.40M 299.11M 262.22M 191.67M
Current deferred revenue 38.61M 152.43M 166.08M 128.08M -
Net debt 172.88M 290.65M -27.26500M 209.78M 84.37M
Short term debt 44.00M 37.91M 36.20M 39.28M 13.80M
Short long term debt 5.00M - - - -
Short long term debt total 247.01M 323.54M 135.41M 215.94M 89.20M
Other stockholder equity -1435.99900M -1383.55200M -861.17500M -737.26900M -671.93800M
Property plant equipment 335.38M 318.73M 187.82M 175.76M 162.03M
Total current assets 272.61M 230.29M 329.40M 190.67M 159.84M
Long term investments - 98.88M 88.81M 77.45M 65.62M
Net tangible assets 108.79M -63.41400M 204.53M 22.87M 12.51M
Short term investments - - 88.81M - -
Net receivables 139.41M 137.22M 126.85M 143.83M 119.50M
Long term debt 92.50M 185.00M 0.00000M 90.00M 89.20M
Inventory 10.27M 10.11M 7.09M 7.46M 5.71M
Accounts payable 41.88M 73.02M 54.23M 51.10M 50.15M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 2.34M 2.31M 2.34M
Additional paid in capital - - - - -
Common stock total equity - 36.51M 36.26M 35.81M 35.31M
Preferred stock total equity - - - - -
Retained earnings total equity - 1970.31M 1723.78M 1425.75M 1225.62M
Treasury stock - -2430.09400M -1822.57900M -1597.94000M -1446.29600M
Accumulated amortization - - - - -
Non currrent assets other 153.00M 8.14M -11.90500M -9.45600M 9.21M
Deferred long term asset charges - - - - -
Non current assets total 1169.40M 1112.44M 1105.51M 1077.65M 815.69M
Capital lease obligations 149.51M 138.54M 135.41M 125.94M -
Long term debt total 92.50M 185.00M 0.00000M 90.00M 89.20M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -59.40200M -57.75700M -61.56000M -190.76000M -105.22500M
Change to liabilities 15.34M 9.83M 44.94M 40.93M 31.28M
Total cashflows from investing activities -59.40200M -57.75700M -61.56000M -190.76000M -105.22500M
Net borrowings -99.38400M 196.88M -99.84900M -3.12700M -14.58300M
Total cash from financing activities -209.25300M -380.62000M -271.21200M -109.16200M -188.20300M
Change to operating activities -45.26100M -4.78600M -1.33200M 0.00800M -4.75800M
Net income 249.62M 268.55M 319.47M 219.92M 205.54M
Change in cash 41.23M -129.78000M 156.52M 1.33M -6.29000M
Begin period cash flow 32.90M 162.68M 6.16M 4.83M 11.12M
End period cash flow 74.13M 32.90M 162.68M 6.16M 4.83M
Total cash from operating activities 309.89M 308.60M 489.29M 301.25M 287.14M
Issuance of capital stock - - - - -
Depreciation 59.17M 59.05M 56.58M 45.20M 38.86M
Other cashflows from investing activities -2.07700M 0.92M -2.72900M -137.73800M -52.35300M
Dividends paid 22.02M 22.02M 21.08M 19.79M 18.66M
Change to inventory -0.16200M -3.01400M 0.37M -1.75700M -0.35100M
Change to account receivables -2.41400M -8.43100M 12.77M -19.24700M -5.57000M
Sale purchase of stock -114.51500M -576.04200M -175.59400M -92.63100M -158.88400M
Other cashflows from financing activities 236.53M -0.16500M 0.26M 0.48M -1.99000M
Change to netincome 34.24M 7.49M 32.16M 25.97M 24.69M
Capital expenditures 57.33M 58.67M 58.83M 53.02M 52.87M
Change receivables - -8.43100M 12.77M -19.24700M -5.57000M
Cash flows other operating - -35.03500M 22.70M -10.08000M -7.76300M
Exchange rate changes - - - - -
Cash and cash equivalents changes - -129.78000M 156.52M 1.33M -6.29000M
Change in working capital -33.49000M -26.80000M 44.43M 7.58M 17.15M
Stock based compensation -0.01560M 31.42M 26.80M 23.60M 0.45M
Other non cash items 37.94M -7.84900M 4.23M 7.71M 19.94M
Free cash flow 252.56M 249.92M 430.46M 248.23M 234.27M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CHE
Chemed Corp
-2.71 0.67% 400.76 36.76 25.06 3.92 8.57 3.91 22.80
HCA
HCA Holdings Inc
-7.49 1.37% 537.64 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
0.05 0.36% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA
- -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc
- -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Chemed Corp

255 East Fifth Street, Cincinnati, OH, United States, 45202-4726

Key Executives

Name Title Year Born
Mr. Kevin J. McNamara CEO, Pres & Director 1954
Mr. David P. Williams Exec. VP & CFO 1961
Mr. Michael D. Witzeman CPA, MBA VP & Controller 1971
Mr. Nicholas Michael Westfall Exec. VP 1979
Ms. Lisa A. Reinhard VP, Chief Admin. Officer & Assistant Sec. NA
Sherri Warner Director of Investor Relations NA
Mr. Brian C. Judkins VP, Sec. & Chief Legal Officer 1981
Mr. Thomas C. Hutton VP & Director 1951

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.